Cord Blood CD34+ Stem/Progenitor Cells, Single Donor, Frozen

Cord Blood CD34+ Stem/Progenitor Cells, Single Donor, Frozen

The CGT Global Difference 

CGT Global is a Biospecimen Provider for a wide range of clinical and preclinical research projects. Our state-of-the-art laboratories and collection centers are located nationwide and provide end-to-end services: These services include:   

  • Process, isolate, and cryopreserve cells immediately after donor collection 
  • Amazing customer service and fast shipping
  • Customize products to distinct study specifications 
  • Retain specific donor demographics and a safe, highly recallable donor pool 
  • HLA Typed Primary Cells
  • Biobanked cells
CGT Global - Landing Page Desktop Prototype

Description

CD34 is a glycosylated transmembrane protein and represents a well-established marker for human hematopoietic stem and progenitor cells in peripheral blood, bone marrow, and cord blood. CD34+ cells are self-renewing, multipotent stem cells that give rise to all blood cells of the immune system through a process called hematopoiesis. As hematopoietic stem cells progress through hematopoiesis they generate the myeloid (monocytes, macrophages, granulocytes, megakaryocytes, dendritic cells, erythrocytes) and lymphoid (T cells, B cells, NK cells) lineages. The highly specialized cells that arise from hematopoietic stem cells work collaboratively in defending the body against infection and disease.

Human cord blood CD34+ stem and progenitor cells are positively selected using immunomagnetic anti-CD34 (clone QBEND10) microbeads from the mononuclear cell fraction. Isolated cells are characterized by flow cytometry prior to cryopreservation to ensure a highly pure and viable cell population.

Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.

Additional information

Anticoagulant

Format

Grade

Species

Cell and Tissue Source

Disease State

Donor Attributes

Certificate of Analysis

Sample CoA

Material Safety Data Sheet

Request More Information

Name(Required)
Hidden
Product Interest(Required)
This field is for validation purposes and should be left unchanged.

Halkias et al. (2015) Conserved and Divergent Aspects of Human T-cell Development and Migration in Humanized Mice. Immunol Cell Biol 1-11. doi:10.1038/icb.2015.38.

Read Article

Cleyrat et al. (2017) Gene Editing Rescue of a Novel MPL Mutant Associated with Congenital Amegakaryocytic Thrombocytopenia. Blood Advances 1: 1815-1826. doi.org/10.1182/bloodadvances.201600291.

Read Article

Takahashi et al. (2018) Enhanced Antibody Responses in a Novel NOG Transgenic Mouse with Restored Lymph Node Organogenesis. Front. Immunol 1(17). doi.org/10.3389/fimmu.2017.02017.

Read Article

Ito et al. (2020) Bovine β-Lactoglobulin-Induced Passive Systemic Anaphylaxis Model Using Humanized NOG hIL-3/hGM-CSF Transgenic MiceInt Immunol. DOI: 10.1093/intimm/dxaa067.

Read Article